The U.S. is set to begin testing drugs on children, a step researchers say many drugmakers skipped because it was risky and costly. “It is an incredibly exciting time,” said Crystal Mackall, a pediatric-cancer researcher. “We have lots of drug companies who want to speak with us suddenly.” Other public health news focuses on a new breast cancer treatment; hemp-derived product regulations; access to dental treatments; killings of transgender people; LGBTQ communities facing bias; exercise’s role during dementia and more.
